CRTC1-MAML2 gene fusion in mucoepidermoid carcinoma of the lacrimal gland

Oncology Reports

Volumn 27, Issue 5, 2012, Pages 1413-1416

  Von Holstein, Sarah Linéa ^a,c   Fehr, André ^c   Heegaard, Steffen ^a   Therkildsen, Marianne Hamilton ^b   Stenman, Göran ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Biomarker; CRTC1; Fusion oncogene; Lacrimal gland; MAML2; Mucoepidermoid carcinoma

Indexed keywords

BIOLOGICAL MARKER; CRTC1 PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MAML2 PROTEIN; NUCLEAR PROTEIN; UNCLASSIFIED DRUG;

ADENOSQUAMOUS CARCINOMA; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER RECURRENCE; CASE REPORT; CRTC1 GENE; DIAGNOSTIC VALUE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE; GENE FUSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LACRIMAL GLAND ADENOCARCINOMA; LACRIMAL GLAND DISEASE; LACRIMAL GLAND TUMOR; MALE; MAML2 GENE; METASTASIS POTENTIAL; MICROSCOPY; ORBIT RECONSTRUCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL; TUMOR VOLUME;

ACRIDINE ORANGE; AGED; CARCINOMA, MUCOEPIDERMOID; DNA-BINDING PROTEINS; EYE NEOPLASMS; GENE EXPRESSION; HUMANS; LACRIMAL APPARATUS; MALE; NUCLEAR PROTEINS; ONCOGENE PROTEINS, FUSION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84858221333     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1676     Document Type: Article

References (17)

1. Eviatar JA and Hornblass A: Mucoepidermoid carcinoma of the lacrimal gland: 25 cases and a review and update of the literature. Ophthal Plast Reconstr Surg 9: 170-181, 1993. (Pubitemid 23260815)
2. Sofinski SJ, Brown BZ, Rao N and Wan WL: Mucoepidermoid carcinoma of the lacrimal gland. Case report and review of the literature. Ophthal Plast Reconstr Surg 2: 147-151, 1986. (Pubitemid 17032199)
3. Font RL, Croxatto JO and Rao NA: Tumors of the lacrimal gland. In: Tumors of the Eye and Ocular Adnexa. 1st edition. Silverberg SG (ed). American Registry of Pathology/Armed Forces Institute of Pathology, Washington, pp223-246, 2006.
4. Goode RK and El Naggar AK: Mucoepidermoid carcinoma. In: World Health Organization Classification of Tumors. Pathology and Genetics Head and Neck Tumours. 1st edition. Barnes L, Eveson J, Reichart P and Sidransky D (eds). IARC Press, Lyon, pp219-220, 2005.
5. Nordkvist A, Gustafsson H, Juberg-Ode M and Stenman G: Recurrent rearrangements of 11q14-22 in mucoepidermoid carcinoma. Cancer Genet Cytogenet 74: 77-83, 1994. (Pubitemid 24208871)
6. Tonon G, Modi S, Wu L, Kubo A, Coxon AB, Komiya T, O'Neil K, Stover K, El-Naggar A, Griffin JD, Kirsch IR and Kaye FJ: t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. Nat Genet 33: 208-213, 2003. (Pubitemid 36177076)
7. Enlund F, Behboudi A, Andren Y, Öberg C, Lendahl U, Mark J and Stenman G: Altered Notch signaling resulting from expression of a WAMTP1-MAML2 gene fusion in mucoepidermoid carcinomas and benign Warthin's tumors. Exp Cell Res 292: 21-28, 2004. (Pubitemid 38058260)
8. Stenman G: Fusion oncogenes and tumor type specificity - insights from salivary gland tumors. Semin Cancer Biol 15: 224-235, 2005.
9. Coxon A, Rozenblum E, Park YS, Joshi N, Tsurutani J, Dennis PA, Kirsch IR and Kaye FJ: Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes. Cancer Res 65: 7137-7144, 2005. (Pubitemid 41161243)
10. Wu L, Liu J, Gao P, Nakamura M, Cao Y, Shen H and Griffin JD: Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activation. EMBO J 24: 2391-2402, 2005. (Pubitemid 41032590)
11. Behboudi A, Enlund F, Winnes M, Andren Y, Nordkvist A, Leivo I, Flaberg E, Szekely L, Makitie A, Grenman R, Mark J and Stenman G: Molecular classification of mucoepidermoid carcinomas-prognostic significance of the MECT1-MAML2 fusion oncogene. Genes Chromosomes Cancer 45: 470-481, 2006.
12. Okabe M, Miyabe S, Nagatsuka H, Terada A, Hanai N, Yokoi M, Shimozato K, Eimoto T, Nakamura S, Nagai N, Hasegawa Y and Inagaki H: MECT1-MAML2 fusion transcript defines a favorable subset of mucoepidermoid carcinoma. Clin Cancer Res 12: 3902-3907, 2006. (Pubitemid 44078073)
13. Seethala RR, Dacic S, Cieply K, Kelly LM and Nikiforova MN: A reappraisal of the MECT1/MAML2 translocation in salivary mucoepidermoid carcinomas. Am J Surg Pathol 34: 1106-1121, 2010.
14. Tirado Y, Williams MD, Hanna EY, Kaye FJ, Batsakis JG and El-Naggar AK: CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: implications for histogenesis and biologic behavior. Genes Chromosomes Cancer 46: 708-715, 2007. (Pubitemid 46802338)
15. Lennerz JK, Perry A, Mills JC, Huettner PC and Pfeifer JD: Mucoepidermoid carcinoma of the cervix: another tumor with the t(11;19)-associated CRTC1-MAML2 gene fusion. Am J Surg Pathol 33: 835-843, 2009.
16. Komiya T, Park Y, Modi S, Coxon AB, Oh H and Kaye FJ: Sustained expression of Mect1-Maml2 is essential for tumor cell growth in salivary gland cancers carrying the t(11;19) translocation. Oncogene 25: 6128-6132, 2006. (Pubitemid 44562411)
17. Winnes M, Molne L, Suurkula M, Andren Y, Persson F, Enlund F and Stenman G: Frequent fusion of the CRTC1 and MAML2 genes in clear cell variants of cutaneous hidradenomas. Genes Chromosomes Cancer 46: 559-563, 2007. (Pubitemid 46649570)